The aim of the study was to document the effects of short courses of fluoroquinolones given during an outbreak of multidrug resistant typhoid fever in southern Viet Nam on the growth of children over a period of two years. In a prospective cohort study, 326 Vietnamese children aged between 1 and 14 years were followed up for two years after receiving either ciprofloxacin (70 mg/kg given over 7 d) (n= 173) or ofloxacin (45-50 mg/kg given over 3-5 d) (n= 153) for suspected typhoid fever. Growth velocity and weight for height were compared with an age matched control group of children from the same locality (n=223) who had not contracted typhoid or received any fluoroquinolones. In the ofloxacin and ciprofloxacin treated patients there was no evidence of acute joint toxicity, nor of any joint symptoms attributable to either of the fluoroquinolones. There was no difference in expected weight for height measurements between the three groups of children over the two year period. During the first year, height velocity in ciprofloxacin treated children was greater than in either ofloxacin treated children or untreated controls. Height velocity in the latter two groups was not significantly different. After two years height velocity was similar in the three groups. The results support the use of short course fluoroquinolone treatment in childhood typhoid, especially when caused by strains resistant to other antibiotics. (Arch Dis Child 1996; 74: 44-46) 
In many parts of the developing world, multidrug resistant strains of Salmonella typhi are spreading rapidly. 14 These strains are resistant to generally available oral antimicrobial agents, but they remain highly sensitive to the fluoroquinolones. Short treatment courses with oral fluoroquinolones of just five or seven days' duration are relatively cheap, well tolerated, and very effective for the treatment of multidrug resistant typhoid fever.3 5 The fluoroquinolones are well absorbed broad spectrum antibiotics with an excellent safety record. 6 However, their use in children has been contraindicated because of cartilage toxicity seen mainly in the weight bearing joints of young experimental animals (beagle dogs and rats).7-10 While evidence supporting the safety of fluoroquinolones in children with cystic fibrosis is accumulating gradually,'1-14 most paediatricians remain unwilling to prescribe these drugs routinely. We describe here the results of a two year follow up study of children who received a single short course of either ofloxacin or ciprofloxacin during a typhoid epidemic in southern Viet Nam. We assumed that quinolone toxicity in children would present either acutely as pain in one or more weight bearing joints, or more insidiously as a detectable reduction in growth velocity over a period of one or two years.
Methods
In April 1993 the Centre for Tropical Diseases was asked to help control a typhoid epidemic affecting two hamlets in Kien Giang Province, in the Mekong Delta region of southern Viet Nam. Many of the patients were children, and two had already died. The epidemic strain of S typhi was resistant to ampicillin, chloramphenicol, sulphamethoxazole, tetracycline, and trimethoprim. Thus fluoroquinolones were the only effective oral agents that could be used for treatment.
Treatment
The local health authority obtained a temporary supply of ciprofloxacin ( Age (y), mean (95% CI) 7-6 (7-2 to 8 0) 7-8 (7 4 to 8 CI=confidence interval.
*Difference between ciprofloxacin group and controls p=003. tDifference between ciprofloxacin and ofloxacin groups p=0 04.
because of their acceptability, rapid oral absorption, good intracellular penetration, and speed of action.6 19 Salmonellae are extremely sensitive, and multidrug resistant infections can be cured with only three days of treatment. 15 Indeed there is no orally active alternative for the treatment of multidrug resistant infections with S typhi. The height gains overall in this series were less then predicted from the TannerWhitehouse charts, which were derived from observations in English schoolchildren 20 years ago (as local data are not available). This was expected, as overall heights in Viet Nam are lower than in the United Kingdom. The results suggested improved growth over one year after a week's course of ciprofloxacin at a relatively high dose. This was not a randomised study, and so there may have been some selection bias to account for the differences in growth observed between the groups. However, the improved growth in the ciprofloxacin group could have resulted from an antibacterial effect. The study was carried out in a poor rice farming community where many of the children were undernourished and may have had intestinal microflora which impaired intestinal nutrient absorption. Abnormalities in jejunal microflora have been widely implicated in the diarrhoea-malabsorption-malnutrition cycle.2021 This is treatable with antibiotics. The fluoroquinolones are known to reach very high concentrations in the intestine and may have been acting against upper gastrointestinal microflora which were impairing absorption. The ofloxacin treated patients did not show any growth advantage after one year, but these patients received shorter courses of treatment and approximately half the antibiotic dose overall compared to the ciprofloxacin treated children. The observed differences in height velocity had disappeared at the two year review.
On the basis of these and other data there seems no reason to withhold short courses of fluoroquinolones from children when alternative unrestricted therapies are either unavailable or inappropriate.
